Company
Tipping Point Biosciences
Pioneering new therapies for diseases of chromatin dysfunction.
Also known as TippingPoint Biosciences
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Francisco, CA, United States
Claim, correct or request removal
Record updated 28 September 2026
About
TippingPoint Biosciences' mission is to treat diseases caused by dysfunctional genome chromatin packaging that are difficult to target using conventional approaches.
Funding snapshot
- Latest round
- Pre seed2024-09-04
Funding rounds
- Pre seed
- 2024-09-04
Loading relationship preview